Polymorphic genotypes of the HRES-1 human endogenous retrovirus locus correlate with systemic lupus erythematosus and autoreactivity

Polymorphic genotypes of the HRES-1 human endogenous retrovirus locus correlate with systemic lupus erythematosus and autoreactivity
复制标题

DOI:
10.1007/s002510050561
复制
发表时间:
1999-09-01
期刊:
影响因子:
3.2
通讯作者:
Perl, A
Perl, A
中科院分区:
医学4区
文献类型:
--
作者:
Magistrelli, C;Samoilova, E;Perl, A

文献摘要

被引文献

相似文献

抗核自身抗体是系统性红斑狼疮(SLE)的标志。HRES-1/p28(一种28000 M-r核蛋白)的自身抗体常见于SLE患者。HRES-1是一种单拷贝内源性逆转录病毒元件,定位于人类1号染色体q42。一个多态的Hin dIII位点定义了基因组位点的两种不同的等位基因形式,HRES-1/1探针[5.5千碱基(kb)]对三个多态片段进行了检测,可以区分三种基因型:I,只有5.5 kb片段;II,仅3.7 kb和1.8 kb片段;从ⅰ型和ⅱ型纯合的人DNA样本中克隆HRES-1基因座,鉴定出HRES-1多态位点为长末端重复区653位的G - C过渡位点。家族研究显示HRES-1位点的Hin dIII基因型以孟德尔模式遗传,SLE患者中基因I型相对于基因III型的相对频率(14:40=0.35)比100个种族匹配的对照供者(47:43 = 1.09;P = 0.0084)低3.1倍(14:40=0.35)。SLE患者基因I型和基因II型等位基因的频率(68/ 52)低于正常供者(137/63;P=0.033),提示HRES-1基因座的基因I型等位基因可能对SLE具有保护作用。重组HRES-1/p28在基因I型患者中有4/14(29%)和13/19(68%)具有Western blot血清反应性(P < 0.05)
Antinuclear autoantibodies are a hallmark of systemic lupus erythematosus (SLE). Autoantibodies to HRES-1/p28, a 28 000 M-r nuclear protein, commonly occur in patients with SLE. HRES-1 is a single-copy endogenous retroviral element mapped to human Chromosome 1 at q42. A polymorphic Hin dIII site defines two different allelic forms of the genomic locus, The HRES-1/1 probe [5.5 kilobases (kb)] anneals to three polymorphic fragments and three genotypes can be differentiated: I, 5.5 kb fragment only; II, 3.7 kb and 1.8 kb fragments only; and III, all three polymorphic fragments, By cloning of the HRES-1 locus from homozygous type I and type II human DNA samples, the polymorphic Hin dIII site was identified as a G to C transition at position 653 of the long terminal repeat region. Family studies showed that Hin dIII genotypes of the HRES-1 locus are inherited in a Mendelian pattern, The relative frequency of genotype I with respect to genotype III was 3.1-fold lower in patients with SLE (14:40=0.35) in comparison to 100 ethnically matched control donors (47:43 = 1.09; P = 0.0084). Frequency of genotype I vs genotype II alleles was lower in SLE (68/ 52) than in normal donors (137/63; P=0.033), suggesting that a genotype I allele of the HRES-1 locus may be protective against SLE. Western blot seroreactivity with recombinant HRES-1/p28 was noted in 4/14 (29%) of genotype I patients and 13/19 (68%) of genotype III patients (P